{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "2484376", "DateCompleted": {"Year": "1990", "Month": "10", "Day": "19"}, "DateRevised": {"Year": "2019", "Month": "10", "Day": "22"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0163-4984", "JournalIssue": {"Volume": "19", "Issue": "1-2", "PubDate": {"Year": "1989", "Season": "Jan-Feb"}}, "Title": "Biological trace element research", "ISOAbbreviation": "Biol Trace Elem Res"}, "ArticleTitle": "In vitro studies of iron bioavailability. Probing the concentration and oxidation-reduction of pinto bean iron with ferrous chromogens.", "Pagination": {"StartPage": "25", "EndPage": "40", "MedlinePgn": "25-40"}, "Abstract": {"AbstractText": ["The bioavailability of iron from foods is ultimately determined by interactions between iron and other components in the digestive milieu. Perhaps the most important factor is the concentration of Fe2+ during transit through the duodenum. During in vitro simulations of human digestion it is possible to probe the concentration of Fe2+, the rate of Fe2+ formation, and total iron concentration using ferrous chromogens. It is crucial, of course, that the chromogen not interfere with the redox reactions occurring during digestion. Accordingly, ferrozine was examined with regard to its ability to reduce complexes Fe3+, alter rates of Fe3+ production, detect Fe2+ present in the digestive mixture and differentiate the effects of chelating and reducing agents in the mobilization of iron from pinto beans. The chromogen was found to be free from apparent artefacts and to be a sensitive and reproducible probe of the state of iron in digestive mixtures."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Biophysics, Texas A & M University, College Station 77843."}], "LastName": "Chidambaram", "ForeName": "M V", "Initials": "MV"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Reddy", "ForeName": "M B", "Initials": "MB"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Thompson", "ForeName": "J L", "Initials": "JL"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Bates", "ForeName": "G W", "Initials": "GW"}], "GrantList": [{"GrantID": "AM-32163", "Acronym": "AM", "Agency": "NIADDK NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biol Trace Elem Res", "NlmUniqueID": "7911509", "ISSNLinking": "0163-4984"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Chelating Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Chromogenic Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Ferrous Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenanthrolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Triazines"}, {"RegistryNumber": "28048-33-1", "NameOfSubstance": "Ferrozine"}, {"RegistryNumber": "40795-59-3", "NameOfSubstance": "4,7-diphenylphenanthroline sulfonate"}, {"RegistryNumber": "E1UOL152H7", "NameOfSubstance": "Iron"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Biological Availability"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Chelating Agents"}, {"QualifierName": [], "DescriptorName": "Chromogenic Compounds"}, {"QualifierName": [], "DescriptorName": "Digestion"}, {"QualifierName": ["analysis"], "DescriptorName": "Fabaceae"}, {"QualifierName": ["metabolism"], "DescriptorName": "Ferrous Compounds"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ferrozine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Hydrogen-Ion Concentration"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": ["pharmacokinetics"], "DescriptorName": "Iron"}, {"QualifierName": [], "DescriptorName": "Oxidation-Reduction"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Phenanthrolines"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Triazines"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Acta Med Scand Suppl. 1962;376:51-8", "ArticleIdList": ["13873150"]}, {"Citation": "Am J Clin Nutr. 1981 Jul;34(7):1392-401", "ArticleIdList": ["7258129"]}, {"Citation": "Am J Clin Nutr. 1981 Oct;34(10):2257-63", "ArticleIdList": ["7293953"]}, {"Citation": "Rev Invest Clin. 1977 Oct-Dec;29(4):277-82", "ArticleIdList": ["601356"]}, {"Citation": "J Biol Chem. 1981 Dec 10;256(23):12034-9", "ArticleIdList": ["7298642"]}, {"Citation": "J Lab Clin Med. 1976 Sep;88(3):477-86", "ArticleIdList": ["956699"]}, {"Citation": "Biochim Biophys Acta. 1973 Nov 2;329(1):156-8", "ArticleIdList": ["4206209"]}, {"Citation": "Gac Med Mex. 1973 Aug;106(2):131-9", "ArticleIdList": ["4754818"]}, {"Citation": "J Biol Chem. 1971 Jun 10;246(11):3679-85", "ArticleIdList": ["5578914"]}, {"Citation": "Am J Clin Nutr. 1981 Oct;34(10):2248-56", "ArticleIdList": ["6794346"]}, {"Citation": "J Clin Invest. 1939 Sep;18(5):553-80", "ArticleIdList": ["16694687"]}, {"Citation": "Rev Invest Clin. 1973 Jan-Mar;25(1):1-7", "ArticleIdList": ["4805164"]}, {"Citation": "Annu Rev Nutr. 1981;1:123-47", "ArticleIdList": ["6764713"]}, {"Citation": "Biochem J. 1936 Apr;30(4):582-91", "ArticleIdList": ["16746056"]}], "ReferenceList": []}], "History": [{"Year": "1989", "Month": "1", "Day": "1"}, {"Year": "1989", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1989", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["2484376", "10.1007/BF02925447"]}}]}